Alzheimer's Disease Trial, Recruiting NCT07732842 Sponsor: Centre Hospitalier Esquirol Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07732842
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with a Mini-Mental State Examination (MMSE) score above 20 — a standard test used to measure memory and thinking ability (confirm with trial site)
  • People who have at least one family member or carer who knows them well and can reliably support their participation
  • People who are under legal protection arrangements such as guardianship or curatorship are not automatically excluded
  • People with Alzheimer's disease who score above zero on a measure called the SRI (which relates to a specific type of memory symptom) will be placed in one subgroup; the first 30 people with an Alzheimer's disease diagnosis who score zero on the SRI will form a separate subgroup
  • Healthy volunteers (without Alzheimer's disease or memory conditions) with an MMSE score of 26 or above out of 30, whose age and educational/social background are similar to those of the Alzheimer's disease participants
  • Healthy volunteers will be recruited through a specific memory centre in Limoges, France
  • One specific individual with severe memory loss caused by damage to a brain structure called the fornix, following complications from brain surgery — this person has already participated in a related study and does not have Alzheimer's disease
  • That specific individual is under legal guardianship and is monitored at the memory centre in Limoges

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with Alzheimer's disease who do not have an identified family member or carer who can support their participation
  • People who have had a problem with alcohol or other substance dependence at any point in the past 12 months
  • People who have any other neurological condition (a condition affecting the brain or nervous system), apart from the one individual with anterograde amnesia who is already identified in the study
  • People with a history of moderate to severe head injury, stroke, or developmental disorders

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 555431215

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Esquirol
Registry
ClinicalTrials.gov
Start date
24 June 2021
Est. completion
24 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Characterize the type of repetitive behaviour (RB) observed in AD and estimate its frequency in this disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov